Summary
To maintain the health, function and overall well-being of an aging population, we must consider the effectiveness and comparative effectiveness of treatment approaches, as well as the cost and cost-effectiveness of preventive and treatment services. Evidence-based programs (EBPs) to help adults to maintain their health and independence have been deployed by 27 states through both public and private partnerships. These EBPs do not require expensive technology, are acceptable to adults across the age span, and have shown to be effective in managing as well as preventing the consequences of chronic conditions. Yet, there has been limited success in sustaining such programs without philanthropic support, government subsidy or out-of-pocket expenses. EBPs should be used to complement patient-centered medical care with the potential of reducing higher-intensity, higher-cost care.
Introduction
Over the past 10 to 15 years a plethora of alarming predictions from politicians, the media and even economists have indicated that the aging of our population is and will be one of the key contributors to the exorbitant growth in healthcare costs—especially when considering the fiscal impact on the government through Medicare spending. We are undoubtedly facing demographic changes. There has been a decline in the fertility rate during the last century (with the exception of the baby boomer years of 1946–1964) in conjunction with a steady increase in longevity. Furthermore, people are now living beyond the life expectancy predicted when Medicare was enacted 50 years ago. In the current economic environment, how will we be able to curb the runaway costs of healthcare services for a “graying” population with more healthcare needs?
During the second half of the twentieth century, we have also experienced an explosion in new medical technology. New diagnostic and interventional technologies and blockbuster pharmaceuticals, along with more intensive use of medical care, have been significant contributors to increased longevity, allowing us to live longer and hopefully with improved quality of life. As a society we have paid a price for this evolving medical technology. People are indeed living longer, but often with more chronic conditions—cardiovascular diseases, diabetes, arthritis, Alzheimer’s disease/dementia—which require more healthcare services and increased costs. Economic data make clear that these miracles of modern medicine have played a major role in the dramatic increase in healthcare spending and its growing percentage of our GDP (Schultz and Binstock 2006).
Given this confluence of aging and the high cost of high-tech health care, what are the most effective ways to maintain the health, function and overall well-being of an aging population? We must consider the effectiveness and comparative effectiveness (Ommaya and Kupersmith 2011) of treatment approaches, as well as the cost and cost-effectiveness of preventive and treatment services, if we are going to be able to improve the current picture.